Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Riot Platforms Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Riot Platforms Inc trades at $14.48 (market cap $5.66B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Riot Platforms Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Riot Platforms Inc for 16 Days on average.
| IONS | RIOT | |
|---|---|---|
Market Cap | $7.10B | $5.66B |
Volume | 2,027,457 | 21,816,889 |
Sector | Health | Financials |
52-Week High | $86.50 | $28.67 |
52-Week Low | $42.38 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $6.66B | $6.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT trades at $16.67, up 1.21% today, while showing bearish technical signals with 13 of 13 moving averages indicating sell signals. The company reported significant losses with a net income margin of -196.28% in 2026 and has missed earnings expectations for three consecutive quarters. However, analyst sentiment remains overwhelmingly positive with 94.74% buy ratings and a $31.64 consensus price target, reflecting optimism about the company's strategic shift toward data center operations and AI power capacity.
RIOT faces substantial fundamental challenges with persistent losses and negative cash flow, but the company's pivot to data center landlord strategy with $9.8 billion in contracted lease revenue through 2048 provides long-term revenue visibility. The stock offers significant upside potential if management can execute the business transition successfully, though investors must weigh the high valuation multiples against ongoing profitability concerns and execution risks in the competitive AI infrastructure market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
